Composition
- Active ingredients
- RAMIPRIL 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RAMIPRIL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA022021-003 · Discontinued
- RAMIPRIL 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA022021-001 · Discontinued
- RAMIPRIL 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
- RAMIPRIL 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA022021-002 · Discontinued
- RAMIPRIL 10MG · CapsuleNDA019901-004 · Discontinued
- RAMIPRIL 2.5MG · CapsuleNDA019901-002 · Discontinued
- RAMIPRIL 5MG · CapsuleNDA019901-003 · Discontinued
- RAMIPRIL 1.25MG · CapsuleNDA019901-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022021.
At a glance
- Brand name
- Altace
- Active substance
- ramipril
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- King Pfizer
- Status
- Discontinued
- FDA approval
- 27 Feb 2007
- Application
- NDA022021-004